Core Viewpoint - The ongoing legal case against Shanghai Longyu Data Co., Ltd. (formerly known as Longyu Tui) involves allegations of false statements in securities, with investors still eligible for compensation as the statute of limitations has not expired [1][5]. Group 1: Allegations of Financial Misconduct - Longyu Tui has been found to have inflated revenue and profits in its annual reports from 2019 to 2022, with specific figures indicating a revenue inflation of 2,242.25 million yuan in 2019 (16.61% of reported revenue), 3,985.83 million yuan in 2020 (44.57%), 4,024.21 million yuan in 2021 (50.46%), and 4,288.17 million yuan in 2022 (42.95%) [1][5]. - The inflated profits for the same years were reported as 5.73 million yuan (60.48% of total profit) in 2019, 111.37 million yuan (10.36%) in 2020, 95.20 million yuan (7.48%) in 2021, and 109.33 million yuan (23.92%) in 2022 [1][5]. Group 2: Regulatory Actions - The Shanghai Securities Regulatory Bureau has mandated Longyu Tui to rectify its actions, issued a warning, and imposed a fine of 11.5 million yuan. The former chairman, Xu Zengzeng, received a warning, a fine of 16.9 million yuan, and a ten-year ban from the securities market [2][6]. Group 3: Legal Proceedings and Investor Rights - A court has ruled in favor of some investors in the first instance, allowing them to seek compensation for losses incurred due to the company's false statements. Investors who purchased Longyu Tui shares between April 28, 2020, and April 29, 2024, and still hold them as of the latter date are eligible to file claims [3][7]. - Required documentation for claims includes securities account information, stock reconciliation statements from April 1, 2020, to the present, and contact information [3][7].

2018年12月，东方通收购北京泰策科技有限公司100%股权，泰策科技成为东方通全资子公司。2019年 至2022年期间，东方通通过泰策科技虚构业务、提前确认收入等方式虚增收入、利润，导致东方通披露 的2019年至2022年年度报告存在虚假记载。 二、东方通公告的证券发行文件编造重大虚假内容 东方通（300379）收到股票终止上市决定，投资者索赔已提交多批立案 2025年12月22日，北京东方通科技股份有限公司（证券简称：东方通，证券代码：300379）公告收到深 圳证券交易所《关于北京东方通科技股份有限公司股票终止上市的决定》（深证上〔2025〕1450 号）。深圳证券交易所决定终止公司股票上市交易。公司股票于2025年12月30日复牌并进入退市整理 期，退市整理期为十五个交易日，预计最后交易日期为2026年1月21日。退市整理期间股票在风险警示 板交易。退市整理期首个交易日，公司股票价格无价格涨跌幅限制，此后每日涨跌幅限制为 20%。 此前，2025年11月25日，东方通公告收到中国证券监督管理委员会北京监管局下发的《行政处罚决定 书》，经查，东方通存在以下违法事实： 一、东方通2019年、2020年、2 ...

Core Viewpoint - The investors' lawsuit against Hainan Puli Pharmaceutical Co., Ltd. has seen some success, with some shareholders winning in the first instance, and the opportunity for further claims remains open as the statute of limitations has not yet expired [1][5]. Summary by Sections Legal Case Background - On March 21, 2025, Puli Pharmaceutical announced it received an administrative penalty decision from the China Securities Regulatory Commission, revealing that from 2021 to 2022, the company falsely recognized sales revenue and profits by fabricating sales of finished and raw pharmaceutical products [2][6]. - In 2021, the company overstated its operating revenue by approximately 440 million yuan, accounting for 28.90% of the disclosed revenue, with an inflated profit of about 290 million yuan, representing 62.06% of the total profit [2][6]. - In 2022, the company similarly overstated its operating revenue by about 460 million yuan, which was 25.23% of the disclosed revenue, leading to an inflated profit of approximately 380 million yuan, or 86.36% of the total profit [2][6]. Financial Misrepresentation - The total overstatement of operating revenue for 2021 was 510 million yuan, which constituted 34.07% of the disclosed revenue, with corresponding inflated costs of about 200 million yuan [3][7]. - For 2022, the total overstatement was also 510 million yuan, making up 28.51% of the disclosed revenue, with inflated costs of approximately 130 million yuan [3][7]. - The company’s annual reports for 2021 and 2022 contained false records, which could lead to legal repercussions for the company [3][7]. Investor Compensation - According to the Supreme People's Court's judicial interpretation on false statements, investors whose rights were harmed by such actions can file lawsuits for compensation, which includes losses from investment differences, commissions, and stamp duty [3][7]. - Investors who purchased Puli Pharmaceutical shares between April 26, 2022, and April 16, 2024, and still held them at the close on April 16, 2024, are eligible to claim compensation [3][7]. Claim Process - Investors seeking compensation must provide their securities account information, stock reconciliation statements from April 1, 2022, to the present, and contact information [8].

登录新浪财经APP 搜索【信披】查看更多考评等级 （本文由北京市盈科（深圳）律师事务所徐劲律师（执业证号14403200610948623）供稿，不代表新浪 财经的立场。徐劲律师擅长在上市公司虚假陈述案件中为股民维权索赔，执业十余年来，曾代理投资者 起诉多家上市公司成功索赔。）（徐劲律师专栏） 责任编辑：韦子蓉 登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 2025年12月19日晚间，卓然股份（维权）（688121）发布《关于公司及实际控制人收到立案告知书的公 告》。公告显示：上海卓然工程技术股份有限公司及实际控制人张锦红于2025年12月19日收到中国证券 监督管理委员会出具的《立案告知书》（证监立案字0032025031号、证监立案字0032025032号），因涉 嫌信息披露违法违规等事项，根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法 规，中国证监会决定对公司及实际控制 ...

2．身份证明文件复印件：个人投资者提供本人身份证正反面复印件。 根据西陇科学（维权）股份有限公司（以下简称"西陇科学"）披露的监管信息及相关法律文书，公司因 涉嫌信息披露违法违规，被中国证券监督管理委员会广东监管局立案调查。2023年7月8日，公司收到广 东证监局下发的《行政处罚决定书》，其中查实并认定公司存在重大信息披露违法行为。 该违法行为具体涉及公司未按规定及时、准确地披露重要信息，导致相关定期报告及临时公告存在虚假 记载或重大遗漏，严重违反了《中华人民共和国证券法》及中国证监会关于信息披露的真实、准确、完 整、及时、公平原则，侵害了广大投资者的知情权和财产权益。 上海百悦律师事务所牛彬律师表示，西陇科学已收到正式的行政处罚决定，其虚假陈述事实已被监管部 门认定，因此遭受投资损失的投资者有权依法提起索赔诉讼。根据《中华人民共和国证券法》（2020年 修订）及最高人民法院关于证券虚假陈述民事赔偿的相关司法解释，暂定符合以下条件的投资者（含机 构投资者）可发起索赔：（牛彬律师专栏） 暂定索赔条件： 凡于2021年4月29日至2023年4月29日期间买入西陇科学（002584）股票，并且在2023年4月29日 ...

Core Viewpoint - Peng Bo Shi Telecom Media Group Co., Ltd. has been penalized for violations of information disclosure regulations, including failure to disclose related party transactions and significant omissions in periodic reports, which has harmed investors' rights [1][7]. Group 1: Regulatory Actions - The China Securities Regulatory Commission's Sichuan Regulatory Bureau issued an administrative penalty decision against Peng Bo Shi for failing to disclose non-operating fund transactions with related parties, leading to inaccurate and incomplete annual report disclosures [1][7]. - The violations are considered serious breaches of the Securities Law of the People's Republic of China and related disclosure regulations, infringing on the legitimate rights of investors [1][7]. Group 2: Investor Compensation - Affected investors are entitled to file civil compensation lawsuits due to the company's false statements, as per the revised Securities Law and relevant judicial interpretations [1][7]. - Two categories of investors are preliminarily identified as eligible for compensation: 1. Investors who purchased Peng Bo Shi stock (600804) between April 12, 2013, and July 18, 2023, and sold or continued to hold the stock after July 18, 2023 [2][8]. 2. Investors who bought the stock between April 28, 2022, and April 16, 2024, and sold or continued to hold it after April 16, 2024 [3][8]. Group 3: Required Documentation for Claims - Investors must prepare the following materials to support their claims: 1. Original stock transaction statements, stamped by the brokerage, covering all transactions from the first purchase to the last sale or print date [4][9]. 2. A copy of the investor's ID card, including both sides for individual investors [5][10]. 3. A securities account confirmation letter issued by the brokerage, containing the investor's name, ID number, and account number, also stamped by the brokerage [5][10].

2025年12月16日晚，朗进科技（维权）公告称收到《证监会行政处罚事先告知书》。告知书显示，朗进 科技未及时披露也未在2024年半年度报告披露上述关联方非经营性资金占用，2024 年半年度报告存在 重大遗漏；2024年7月至2025年7月发生关联方非经营性资金占用，朗进科技未及时披露上述关联方非经 营性资金占用。证监会拟对公司、实控人及相关责任给予警告及罚款。部分股民或许存在索赔机会。 暂定索赔条件： 于2024年2月1日至2025年8月27日之间买入，并且在2025年8月27日之后卖出或仍持有而亏损的投资者 （最终索赔结果以法院判决为准）。（朗进科技维权入口） 投资者应准备下列材料：身份证复印件，证券账户开户信息确认单（原件加盖证券公司营业部印章）， 证券交易记录流水（从首次买入该股票至今并加盖证券公司营业部印章，有库存股的还要打印出库存股 数）。 （本文由北京市盈科（深圳）律师事务所徐劲律师（执业证号14403200610948623）供稿，不代表新浪 财经的立场。徐劲律师擅长在上市公司虚假陈述案件中为股民维权索赔，执业十余年来，曾代理投资者 起诉多家上市公司成功索赔。）（徐劲律师专栏） 责任编辑：韦子 ...

Core Viewpoint - The recent developments in the securities fraud case against Tianjin Zhuolang Information Technology Co., Ltd. (formerly known as Zhuolang Technology) have garnered significant attention, with ongoing efforts for investor compensation due to false statements made by the company [1][5]. Group 1: Case Background - On December 26, 2024, Zhuolang Technology announced that it received an administrative penalty decision from the China Securities Regulatory Commission, revealing that from 2019 to 2023, its subsidiary fabricated sales of servers, software, and system integration services, leading to inflated revenue and profits [5][6]. - The company failed to disclose external guarantees as required, resulting in significant omissions in its annual reports for 2019 and 2020 [5][6]. Group 2: Legal Proceedings and Compensation - The statute of limitations for claims against Zhuolang Technology has not yet expired, and multiple groups of investors have submitted litigation materials through the Zhejiang Yufeng Law Firm [1][5]. - According to the Supreme People's Court's judicial interpretation on false statements, investors whose rights were harmed can file lawsuits for compensation, which includes losses from price differences, commissions, and stamp duty [2][6]. - Investors who purchased Zhuolang Technology shares between September 19, 2019, and March 14, 2024, and still held them at the close of trading on March 14, 2024, are eligible for compensation, as confirmed by previous court rulings [3][6]. Group 3: Required Documentation for Claims - Investors seeking compensation must provide specific documentation, including a securities account information query, stock reconciliation statements from September 1, 2019, to the present, and contact information [4][6].

受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我们！ 徐劲律师（北京市盈科（深圳）律师事务所）认为，根据证券虚假陈述新司法解释，已明确取消前置程 序，投资者因上市公司虚假陈述导致损失，可以向有管辖权的法院提起民事赔偿诉讼以维护自己的合法 权益，可索赔损失范围包括投资差额损失、印花税及佣金损失。 暂定索赔条件： 于2025年11月28日前买入，并在2025年11月28日之后卖出或仍持有而亏损的投资者（最终索赔结果以法 院判决为准）。 投资者应准备下列材料：身份证复印件，证券账户开户信息确认单（原件加盖证券公司营业部印章）， 证券交易记录流水（从首次买入该股票至今并加盖证券公司营业部印章，有库存股的还要打印出库存股 数）。 （本文由北京市盈科（深圳）律师事务所徐劲律师（执业证号14403200610948623）供稿，不代表新浪 财经的立场。徐劲律师擅长在上市公司虚假陈述案件中为股民维权索赔，执业十余年来，曾代理投资者 起诉多家上市公司成功索赔。） 责任 ...

Core Points - The China Securities Regulatory Commission (CSRC) has issued a notice of administrative penalty against First Capital Securities for failing to fulfill its supervisory duties during the 2019 convertible bond project of Hongda Xingye [1][5] - Hongda Xingye has previously been penalized for violations related to the misuse of raised funds and false disclosures in its financial reports [2][5] - Investors who purchased Hongda Xingye's stock or convertible bonds between January 6, 2020, and September 22, 2023, may be eligible for compensation if they suffered losses [3][6] Summary of Relevant Sections Administrative Penalty - First Capital Securities is accused of not adequately verifying the use and repayment of raised funds, failing to issue proper supervisory opinions, and not fulfilling reporting obligations, which led to false records in supervisory documents [1][5] - The proposed penalties include a warning, confiscation of underwriting income amounting to approximately 4.25 million yuan, and a fine of about 12.74 million yuan [5] Violations by Hongda Xingye - Hongda Xingye has been found to have changed the intended use of funds raised in 2019 without authorization [2][5] - The company’s annual reports from 2019 to 2022 and the semi-annual report for 2023 contained false records regarding the use of raised funds [2][5] - The company failed to timely disclose significant litigation, arbitration, and guarantee matters [2][5] Investor Compensation - Investors who bought shares or bonds during the specified period and continued to hold or sold at a loss after September 23, 2023, have the right to claim compensation [3][6] - Required documentation for claims includes trading statements and identification copies [7] - Legal representation for claims is typically on a contingency basis, meaning no upfront fees are required, and fees are only paid upon winning the case [7]